Objectives: To identify patient-and disease-related factors related to survival and favorable outcomes for children who underwent extracorporeal cardiopulmonary resuscitation after a refractory cardiac arrest. Conclusions: In this series, extracorporeal cardiopulmonary resuscitation was associated with relatively high survival rates and a good health-related quality of life and family functioning. Larger series are needed to assess whether this technique should be more broadly available in the pediatric critical care community. (Pediatr Crit Care Med 2018; 19:451-458) 
S urvival rate after pediatric cardiopulmonary resuscitation (CPR) for children undergoing cardiac arrest (CA) remains low. In addition to survival, understanding the development of new neurologic disabilities after CA remains challenging (1) .
Extracorporeal CPR (ECPR), defined by the initiation of extracorporeal life support during active chest compressions, has the potential to offer survival and favorable neurologic recovery (2) . In the early 1990s, extracorporeal membrane oxygenation (ECMO) support instituted as rescue therapy during CPR promoted survival in children with cardiac disease who had cardiopulmonary arrest and failed to respond to conventional CPR (3) . Since then, ECPR has been increasingly used as a method to improve survival in patients with refractory CA due to cardiac and noncardiac etiology (4, 5) . An Extracorporeal Life Support Organization (ELSO) registry report that reviewed data from 2004 to 2016 showed an important increase of pediatric ECPR, but did not demonstrate improved survival (6) .
Current pediatric advance life support guidelines recommend that ECPR may be considered for children with underlying cardiac conditions who have an in-hospital CA (IHCA) when appropriate protocols, expertise, and equipment are available (class IIb, Level of Evidence C-Limited Data). Pediatric out-of-hospital CA (OHCA) was not considered for the 2015 International Liaison Committee on Resuscitation systematic review (7) .
ECPR requires significant expertise and resource utilization and is thus not universally available. Skilled personnel for rapid assembly of an ECMO circuit, alongside surgical, medical, and nursing teams are needed to initiate and manage patients on ECMO successfully. In addition, around the clock availability of such a specialized team is a considerable expense and as such, survival and long-term outcomes must justify this strategy. Until recently, data about neurologic outcomes and morbidity have been limited due to a lack of rapid and reliable assessment tools applicable to the wide age range of pediatric patients. Multiple functional and neurologic scales have been used in prior studies such as the Pediatric Overall Performance Category, the Pediatric Cerebral Performance Category, and the Functional Status Scale (8, 9) . The Pediatric Quality of Life Inventory (PedsQL) measurement model is a modular approach to measuring health-related quality of life (HRQOL) in healthy children and adolescents and those with acute and chronic health conditions. The 23-item PedsQL Generic Core Scales were designed to measure the core dimensions of health-physical, emotional, and social-as delineated by the World Health Organization, as well as role (school) functioning (10) . Also, the McMaster Family Assessment Device (MMFAD) has been validated as a singleindex measure to assess family functioning (11) .
The aim of our study is to identify factors related to survival to hospital discharge and describe HRQOL for children who had either IHCA or witnessed OHCA and who underwent in-hospital ECPR at a single center using the PedsQL and the MMFAD.
MATERIALS AND METHODS
This study was approved by the University of Pittsburgh Institutional Review Board. All children who received ECPR for sudden and refractory CA at Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center between May 2007 and July 2015 were included. We retrospectively analyzed data collected from 56 pediatric patients who suffered from sudden and refractory cardiopulmonary arrest and were placed on rescue ECMO during this period of time. Patient demographics, etiology and location of arrest, ECPR duration (defined as the time between initiation of chest compressions and ECMO flow started), and Pediatric Risk of Mortality (PRISM) score before ECMO cannulation were calculated for all medical patients. Laboratory data before and after ECMO cannulation were also obtained. HRQOL and family functioning were assessed with the PedsQL and the MMFAD obtained by scheduled phone interview performed by a research coordinator. Additionally, diagnostic neurologic evaluation of all children undergoing ECPR was assessed by CT, ultrasonography, or MRI.
Patients
The inclusion criteria for determining patients' candidacy for rescue ECMO at our institution included the following: 1) witnessed IHCA or witnessed OHCA; 2) receipt of advanced CPR; 3) no recovery of spontaneous circulation (ROSC) within 15 minutes of CPR; and 4) no contraindication to mechanical circulatory support, such as preexisting severe neurologic abnormality, renal failure, congenital heart defect not correctable by conventional surgery or transplantation, and gestational age less than 35 weeks. Exclusion criteria were contraindication to mechanical circulatory support or anatomic constraints precluding successful cannulation for extracorporeal support.
ECPR Protocol
Our practice is to initiate activation of the emergency ECMO team if ROSC is not achieved within 5 minutes of well-performed CPR when a potentially reversible underlying pathology is considered. Patients were treated with venoarterial ECMO with a standard circuit including a centrifugal pump and an oxygenator.
Before starting ECPR, patients received one dose of heparin (100 U/kg) followed by a continuous infusion to maintain an activated clotting time of 180-200 seconds. Inotropic support was weaned to minimal levels as tolerated to keep mean arterial blood pressure at age-appropriate/targeted levels. Flow rates of 2.5-3 L/m 2 /min were maintained depending on the hemodynamic state, serum lactate levels, and mixed venous oxygen saturation. Mechanical ventilation was continued using low ventilatory rates, positive end-expiratory pressure of 7-10 cm H 2 O, and 30-40% Fio 2 , with all settings adjusted accordingly to minimize barotrauma to the lungs. All patients were given neuromuscular blocking agents, minimal sedation, and narcotic analgesia to permit adequate neurologic evaluation.
Cardiac function was assessed by serial transthoracic echocardiography and hemodynamic stability at reduced rescue ECMO flow. The flow rate was reduced when there was sufficient recovery of cardiac function.
Separation from ECMO was accomplished by gradual flow reduction while increasing inotropic and ventilatory support. Once the patient was off complete support, hemodynamic stability was monitored and tissue perfusion was assessed by serial arterial blood gases with serum lactate, base deficit values, and mixed venous oxygen saturation. For those patients with central cannulation (transthoracic ECMO), delayed sternal closure was performed 2-3 days after decannulation when catecholamine support was minimal or withdrawn. No fundamental changes were instituted in the ECPR protocol during the study period.
Management of Body Temperature After CA
Therapeutic hypothermia was used at the discretion of the multidisciplinary care team. When hypothermia was employed, patients were actively cooled between 34°C and 35°C. In those patients who were not cooled, controlled normothermia was performed avoiding body temperature above 37°C with antipyretic drugs or devices.
descriptively. Demographic data are expressed as absolute and percentage values and continuous data as mean and sd or median and interquartile range (IQR), as appropriate. The chi-square, Fisher exact, and Mann-Whitney U tests were used to compare parametric and nonparametric variables, respectively. A p value of less than 0.05 was considered statistically significant. A multivariable logistic regression to determine variables associated with survival to hospital discharge was conducted. The variables with a p value of less than 0.2 were fitted into the model.
RESULTS

Patient Characteristics
Between May 2007 and July 2015, 56 patients were cannulated during ongoing chest compressions because of refractory CA, with a total of 58 ECPR episodes. Only three out of 58 episodes (5.2%) were OHCA, with 55 (94.8%) being witnessed IHCA.
Median age at arrest in our cohort was 3.5 months (IQR, 1-53). Twenty-three patients were female (39.6%), and the median weight was 6 kg (IQR, 3-20.7) ( Table 1) .
Among the 58 ECPR episodes included in the analysis, 46 (79.3%) occurred in patients with primary cardiac condition (32 [55.2%] being structural heart disease and 12 [20.7%] in patients suffering from noncardiac conditions). Twenty-four episodes of CA followed cardiac surgery. The rest of episodes of CA were not related to surgery (32 [55.2%] related to myocardial failure).
Of those 55 IHCA, 29 (53%) occurred in the cardiac ICU (CICU), 14 (25.5%) in the PICU, five (9%) in the operating room, three (5.3%) in the emergency department, two patients (3.6%) in the catheterization laboratory, and finally two (3.6%) in the neonatal ICU.
Cannulation site was central in 19 patients (32.8%) and peripheral in 37 patients (63.8%): cervical cannulation in 32 patients (55.2%) and multisite (cervical and femoral) in five patients. Two patients (3.4%) required central cannulation due to failure of initial peripheral cannulation (Table 1) . Only one circuit change was required during the study due to evidence of circuit thrombosis. That patient successfully survived decannulation and no abnormal results were reported on the follow-up imaging studies. No other circuit failures were reported during the study period. Survival to ECMO decannulation was 45/58 (77.6%); survival to hospital discharge was 38/58 (65.5%); and survival at the end of the follow-up period was 36/58 (62.1%). Median time of follow-up was 3 years (IQR, 1.5-4.5). Hospital survival in OHCA was 1/3 (33.3%). None of the patients who underwent OHCA survived to the follow-up period (Table 1) . Among the nonsurvivors, withdrawn of life-sustaining therapies was related to multiple organ failure in 13 patients (59.1%), brain death in six patients (27.3%), severe brain injury in two patients (9.1%), and extracorporeal support withdrawn by family request in one patient (4.5%) ( Table 2) .
Risk Factors Associated With Hospital Mortality
Patients who survived were younger than those who did not survive, but these differences did not reach significance (3.5 mo [1 mo to 2 yr] vs 7 mo [1.25 mo to 17 yr]; p = 0.3). No patients undergoing more than one ECPR episode survived at hospital discharge (Table 1) .
Survival among patients with underlying cardiac conditions was 31/46 (67.4%), compared with 5/12 (41.6%) of those with a noncardiac condition (p = 0.09). Based on the cannulation location, patients cannulated in the operating room had an 85.7% of hospital survival, compared with 63% in the CICU, 54% in the PICU, 50% in the catheterization laboratory, and 0% in the emergency department. Survival based on cannulation site was 12/19 (63%) with central cannulation and 23/37 (62%) with peripheral cannulation. Patients who required central cannulation on top of an initial peripheral approach achieved 1/2 survival (50%) ( Table 3) .
Patients who survived had shorter CPR times compared with those who did not survive (28 min [15- (Table 3) . In a multivariate logistic regression analysis, none of the variables were independently associated with hospital mortality.
Patient and Family Outcomes
Brain imaging studies after ECMO decannulation were obtained in 42 out of 58 episodes at a median of 5 days (IQR, 1-29) post-ECPR ( Table 4) . Those studies revealed evidence of intracranial injuries in 15/30 (50%) among survivors compared with 7/12 (58.3%) among nonsurvivors (p = 0.7). Among those studies, eight (36%) revealed acute ischemia, six (28%) intracranial hemorrhage, three (14%) cerebral venous thrombosis, and five studies (22%) revealed diffuse white matter injury (Table 4) .
Among survivors, six (16.7%) were discharged on antiepileptic drugs.
Median age at PedsQL and MMFAD evaluation was 4 years (IQR, 2-7). Median PedsQL score was 84 (76-89. Table 5) . Nevertheless, no statistical differences were found on the psychosocial field of the PedsQL and MMFAD among children with normal brain imaging compared to those with abnormal brain imaging ( Table 5) . No significant statistical differences were found on the PedsQL or MMFAD scores between patients managed with or without hypothermia ( 
DISCUSSION
Overall, our study shows a hospital survival to ECPR of 65.5% and a 3-year follow-up survival of 62.1%, numbers that are relatively higher than those reported in previous ECPR studies and the latest ELSO registry (5, 6, 12) . The most recent ELSO registry data reveal that in last decade, the use of pediatric ECPR has increased 10-fold; however, hospital survival rates have remained consistent, from 39% in 2004 to 41% in 2016 (6) . In addition, two recent ECPR publications also showed lower rates of hospital survival compared with our data. In 2010, Raymond et al (12) , in a multicenter study from the American Heart Association National Registry including neonates, children, and infants, reported a 44% survival to hospital discharge, with higher survival achieved in patients with cardiac diagnosis. Most recently, Garcia Guerra et al (5) reported a 49% survival to hospital discharge and a 43% survival at follow-up in a single-center study including a cohort of 55 patients with a mean age of 34.7 months. Our patient population was younger (median age, 3.5 mo) which in our analysis conferred a survival advantage. These differences in cohorts could have contributed to the better outcomes reported in our study. In our study, the majority of our population suffered from a witnessed IHCA from primary cardiac condition. Although differences in survival rates between cardiac patients and noncardiac patients did not reach statistical significance, these patients tended to have higher survival rates (67.4% vs 41.6%; p = 0.09). Similarly, Joffe et al (13) published, in 2012, a review of studies about ECPR finding that patients with a noncardiac disease were more likely to die. It remains unclear why cardiac patients respond better to extracorporeal support than noncardiac diagnoses. Although further investigations are needed to establish appropriate guidelines, it is noteworthy that the latest American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care strongly supports the use of ECPR in patients with IHCA and those suffering from a cardiac condition (7).
Similar to other pediatric studies, our data demonstrate better survival for those children suffering from IHCA compared with those with OHCA (67.2% vs 33.3%). Furthermore, none of the patients suffering from OHCA survived to follow-up. On the other hand, our IHCA ECPR survival rates are better than those reported in IHCA with advanced CPR (14) . These results align with recently published data showing that in children suffering from IHCA with CPR duration over 10 minutes, ECPR is associated with improved survival to hospital discharge and favorable neurologic outcome when compared with advanced CPR (15) . Therefore, our data add to the growing body of literature that supports the use of ECPR as a life-saving strategy for children with refractory IHCA allowing achieving survival on children who otherwise would be determined to die.
One of our primary objectives was to identify factors associated to ECPR survival. Previous studies demonstrated that ECPR duration time (defined as the time from initiation of chest compressions to successful ECMO flows), higher levels of lactate during the first 24 hours of ECMO, longer time for lactate to normalize after ECMO cannulation, and lower pH values prior and during ECMO were risk factors associated with inhospital mortality (5, (16) (17) (18) . Aligned with those results, in our cohort, patients who survived had shorter ECPR times (28 vs 37.5 min; p = 0.04). Furthermore, having more than one ECPR episode and higher levels of lactate post-ECMO cannulation was associated with in-hospital mortality. When comparing demographics, such as patient age, weight, or gender, these factors were not significant predictors of poor outcome. Similar results have been reported by other authors (17) . In a literature review including 17 ECPR studies published from 2000 to 2011 including 762 children who underwent ECPR between 1990 and 2008, Joffe et al (13) found noncardiac etiology, renal dysfunction, lowest pH, and neurologic complications while on ECMO being the most consistent predictors of mortality. Consistent with these findings in a recent publication including data collected by the Collaborative Pediatric Critical Care Research Network from 2012 to 2014 including 514 patients (267 neonates) undergoing ECMO, Cashen et al (18) reported primary diagnosis of cardiovascular disease, chronic cardiac disease, initiation of ECMO during advanced CPR, development of neurologic event, renal failure, hepatic dysfunction, or thrombotic event were associated with increased relative risk of death. The second main objective of our review was to describe HRQOL and family functioning in those children surviving ECPR. Data on functional outcomes of patients surviving ECPR are scant (13) . In his recent publication including functional data on 282 ECMO survivors collected by the Collaborative Pediatric Critical Care Research Network, Cashen et al (18) reported that 268 of 282 patients (95%) survived hospital discharge without severe functional abnormalities. Nevertheless, no data on functional outcomes were reported from the 70 ECPR patients included in the study (18) . In a previous study including 95 patients undergoing ECMO in our institution from 2006 to 2010, Chrysostomou et al (19) reported that 75% of those had normal to mild disabilities at hospital discharge. In our ECPR survivor cohort, we performed a functional evaluation using the validated functional scales PedsQL and MMFAD (10) . Of interest, both scores used in our population revealed a good quality of life and good family functioning among survivors to ECPR, as median scores of PedsQL and MMFAD obtained were similar to those reported in healthy controls (20, 21) . When comparing brain imaging studies after ECPR, our results showed a higher rate of intracranial injuries than reported in the literature (22, 23) . In 2013, Chrysostomou et al (19) reported a 12% of intracranial injuries after pediatric ECMO support based on CT scan or cerebral ultrasound. Despite a higher rate of abnormal brain imaging after ECMO decannulation in our study, no statistical differences were found between survivors and nonsurvivors. Furthermore, among survivors, those children with a normal brain imaging at the time of ECMO decannulation had statically higher values of physical health and total scores on the PedsQL evaluation, whereas psychosocial field (including language evaluation) was not affected. Despite ECPR survivors having worse brain imaging, they still had good performance at school or at home as shown on the PedsQL and MMFAD scores. Finally, our results corroborate with the results of the THAPCA trial, showing that there was no difference in outcome with therapeutic hypothermia after an ICHA or OHCA in children (24, 25) .
This study has some important limitations. First and foremost, it is a single-center study with a relatively small sample size as CA in children is not as often as in adult population. Second, the intrinsic limitations to functional data obtained by a phone interview provided by a third party without direct observation of the true situation of the patient. Further studies are needed to diminish this lack of detailed neurodevelopmental outcome on survivors of ECPR.
CONCLUSIONS
In light of our results and latest publications, ECPR can be lifesaving when performed in well-trained and designed centers.
Specifically, in relation to our data, ECPR duration, post-ECMO lactate, and history of a prior ECPR event were associated with mortality in our population. Those who received therapeutic hypothermia tended to have higher hospital survival. Further studies are need in this field to proper indications on temperature management.
In conclusion, use of ECPR was associated with high survival rates and a good HRQOL and family functioning in our population. For a greater adoption and confirmation of benefits, larger series encompassing more centers and a wide variety of clinical conditions are needed to assess whether this technique should be more broadly available in the pediatric critical care community.
